Updated Jul 16, 2026
Kovacs Shane William Charles is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $3.30M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-16 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 100.0K | $28.73 | $2.87M |
| 2026-01-16 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 3.8K | $28.01 | $107K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 406 | $9.39 | $4K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 17.9K | $8.66 | $155K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | S — Open-market sale | 16.8K | $9.37 | $157K |
| 2024-12-11 | OLMA | Olema Pharmaceuticals, Inc. | A — Grant or award | 68.2K | $0.00 | |
| 2024-11-18 | OLMA | Olema Pharmaceuticals, Inc. | M — Option exercise | 25.0K | $7.02 | $176K |
Kovacs Shane William Charles is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($3.30M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kovacs Shane William Charles profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.